Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant human adeno-associated virus serotype 2 containing PsCatCh2.0 gene |
|---|---|
| Date Designated: | 10/28/2024 |
| Orphan Designation: | treatment of retinitis pigmentosa |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Zhongmou Therapeutics, Inc. Room 1410, Zhongbu Creative Building, No. 33 Luoyu Road, Hongshan District, Wuhan, Hubei Province China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







